Industry Research Reports
Home > Reports > Service & Software > Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Service & Software
Published Date: 2026-03-12
Pages: 91 Pages
Report ld: 6207868
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Data-Driven Quality Assurance in Pharma Manufacturing Market Size(US$)
CAGR 2026-2032
13.2%
Market Size,2032
USD 5,600
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,662 million
Market Forecast in 2032(Value)
US$ 5,600 million
CAGR
13.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Data-Driven Quality Assurance in Pharma Manufacturing market size was US$ 2379 million in 2025 and is forecast to reach a readjusted size of US$ 5600 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
This report mainly focuses on data-driven quality assurance in pharma manufacturing market. Data-driven quality assurance (DD-QA) refers to the process of pharmaceutical production, through real-time collection, analysis and use of production data (such as process parameters, equipment status, environmental monitoring, quality inspection, etc.), to monitor, predict and optimize production quality in a scientific and automated manner to ensure that drugs comply with regulatory requirements (such as GMP) and improve production efficiency. The core is to use data as the basis for quality decision-making, reduce human intervention, and improve the accuracy and traceability of quality control.
In 2025, the North America Data-Driven Quality Assurance in Pharma Manufacturing market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Data-Driven Quality Assurance in Pharma Manufacturing include FirstEigen, EVERSANA, Ideagen, Incepbio, Exor International S.p.A., ComplianceQuest, Vimachem, Proscia, Amplelogic, Freyr Solutions, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Data-Driven Quality Assurance in Pharma Manufacturing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- FirstEigen
- EVERSANA
- Ideagen
- Incepbio
- Exor International S.p.A.
- ComplianceQuest
- Vimachem
- Proscia
- Amplelogic
- Freyr Solutions
- Thermo Fisher SampleManager LIMS
- Dassault Systèmes
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Real-time Monitoring
- Statistical Quality Control
- Others
Segment by Application
- Process Development and Optimization
- Production Process Control
- Quality Inspection and Release
- Supply Chain and Materials Management
- Others
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Data-Driven Quality Assurance in Pharma Manufacturing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Real-time Monitoring
1.2.3 Statistical Quality Control
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Process Development and Optimization
1.3.3 Production Process Control
1.3.4 Quality Inspection and Release
1.3.5 Supply Chain and Materials Management
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Region (2021-2026)
2.4 Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
2.5.2 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
2.5.3 China Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
2.5.4 Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
2.5.5 Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
2.5.6 India Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
2.5.7 South America Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
2.5.8 Middle East Data-Driven Quality Assurance in Pharma Manufacturing Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Historical Market Size by Type (2021-2026)
3.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Data-Driven Quality Assurance in Pharma Manufacturing
4 Breakdown Data by Application
4.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Historical Market Size by Application (2021-2026)
4.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Data-Driven Quality Assurance in Pharma Manufacturing Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Data-Driven Quality Assurance in Pharma Manufacturing Players by Revenue (2021-2026)
5.1.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Data-Driven Quality Assurance in Pharma Manufacturing Revenue
5.4 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Concentration Analysis
5.4.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Data-Driven Quality Assurance in Pharma Manufacturing Revenue in 2025
5.5 Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing Head Offices and Areas Served
5.6 Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Product and Application
5.7 Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026)
6.1.2.2 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026)
6.1.3.2 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
6.1.4 North America Data-Driven Quality Assurance in Pharma Manufacturing Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026)
6.2.2.2 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026)
6.2.3.2 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
6.2.4 Europe Data-Driven Quality Assurance in Pharma Manufacturing Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026)
6.3.2.2 China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026)
6.3.3.2 China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
6.3.4 China Data-Driven Quality Assurance in Pharma Manufacturing Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026)
6.4.2.2 Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026)
6.4.3.2 Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
6.4.4 Japan Data-Driven Quality Assurance in Pharma Manufacturing Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.5.1 Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026)
6.5.2.2 Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026)
6.5.3.2 Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
6.5.4 Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Major Customers
6.5.5 Southeast Asia Market Trends and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026)
6.6.2 India Market Size by Type
6.6.2.1 India Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026)
6.6.2.2 India Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
6.6.3 India Market Size by Application
6.6.3.1 India Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026)
6.6.3.2 India Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
6.6.4 India Data-Driven Quality Assurance in Pharma Manufacturing Major Customers
6.6.5 India Market Trends and Opportunities
7 Key Player Profiles
7.1 FirstEigen
7.1.1 FirstEigen Company Details
7.1.2 FirstEigen Business Overview
7.1.3 FirstEigen Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.1.4 FirstEigen Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.1.5 FirstEigen Recent Development
7.2 EVERSANA
7.2.1 EVERSANA Company Details
7.2.2 EVERSANA Business Overview
7.2.3 EVERSANA Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.2.4 EVERSANA Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.2.5 EVERSANA Recent Development
7.3 Ideagen
7.3.1 Ideagen Company Details
7.3.2 Ideagen Business Overview
7.3.3 Ideagen Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.3.4 Ideagen Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.3.5 Ideagen Recent Development
7.4 Incepbio
7.4.1 Incepbio Company Details
7.4.2 Incepbio Business Overview
7.4.3 Incepbio Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.4.4 Incepbio Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.4.5 Incepbio Recent Development
7.5 Exor International S.p.A.
7.5.1 Exor International S.p.A. Company Details
7.5.2 Exor International S.p.A. Business Overview
7.5.3 Exor International S.p.A. Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.5.4 Exor International S.p.A. Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.5.5 Exor International S.p.A. Recent Development
7.6 ComplianceQuest
7.6.1 ComplianceQuest Company Details
7.6.2 ComplianceQuest Business Overview
7.6.3 ComplianceQuest Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.6.4 ComplianceQuest Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.6.5 ComplianceQuest Recent Development
7.7 Vimachem
7.7.1 Vimachem Company Details
7.7.2 Vimachem Business Overview
7.7.3 Vimachem Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.7.4 Vimachem Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.7.5 Vimachem Recent Development
7.8 Proscia
7.8.1 Proscia Company Details
7.8.2 Proscia Business Overview
7.8.3 Proscia Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.8.4 Proscia Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.8.5 Proscia Recent Development
7.9 Amplelogic
7.9.1 Amplelogic Company Details
7.9.2 Amplelogic Business Overview
7.9.3 Amplelogic Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.9.4 Amplelogic Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.9.5 Amplelogic Recent Development
7.10 Freyr Solutions
7.10.1 Freyr Solutions Company Details
7.10.2 Freyr Solutions Business Overview
7.10.3 Freyr Solutions Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.10.4 Freyr Solutions Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.10.5 Freyr Solutions Recent Development
7.11 Thermo Fisher SampleManager LIMS
7.11.1 Thermo Fisher SampleManager LIMS Company Details
7.11.2 Thermo Fisher SampleManager LIMS Business Overview
7.11.3 Thermo Fisher SampleManager LIMS Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.11.4 Thermo Fisher SampleManager LIMS Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.11.5 Thermo Fisher SampleManager LIMS Recent Development
7.12 Dassault Systèmes
7.12.1 Dassault Systèmes Company Details
7.12.2 Dassault Systèmes Business Overview
7.12.3 Dassault Systèmes Data-Driven Quality Assurance in Pharma Manufacturing Introduction
7.12.4 Dassault Systèmes Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
7.12.5 Dassault Systèmes Recent Development
8 Data-Driven Quality Assurance in Pharma Manufacturing Market Dynamics
8.1 Data-Driven Quality Assurance in Pharma Manufacturing Industry Trends
8.2 Data-Driven Quality Assurance in Pharma Manufacturing Market Drivers
8.3 Data-Driven Quality Assurance in Pharma Manufacturing Market Challenges
8.4 Data-Driven Quality Assurance in Pharma Manufacturing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Data-Driven Quality Assurance in Pharma Manufacturing Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Share by Region (2021-2026)
Table 6. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Share Forecast by Region (2027-2032)
Table 8. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Type (2021-2026)
Table 10. Global Data-Driven Quality Assurance in Pharma Manufacturing Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Application (2021-2026)
Table 15. Global Data-Driven Quality Assurance in Pharma Manufacturing Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Data-Driven Quality Assurance in Pharma Manufacturing Applications
Table 18. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Players (2021-2026)
Table 20. Global Top Data-Driven Quality Assurance in Pharma Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Data-Driven Quality Assurance in Pharma Manufacturing as of 2025)
Table 21. Ranking of Global Top Data-Driven Quality Assurance in Pharma Manufacturing Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Data-Driven Quality Assurance in Pharma Manufacturing Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Headquarters and Area Served
Table 24. Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Product and Application
Table 25. Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Company (2021-2026)
Table 29. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 35. China Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026) & (US$ Million)
Table 36. China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Company (2021-2026)
Table 37. China Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 38. China Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 39. Japan Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026) & (US$ Million)
Table 40. Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Company (2021-2026)
Table 41. Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 42. Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 43. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026) & (US$ Million)
Table 44. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Company (2021-2026)
Table 45. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 46. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 47. India Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Company (2021-2026) & (US$ Million)
Table 48. India Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Company (2021-2026)
Table 49. India Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2021-2026) & (US$ Million)
Table 50. India Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2021-2026) & (US$ Million)
Table 51. FirstEigen Company Details
Table 52. FirstEigen Business Overview
Table 53. FirstEigen Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 54. FirstEigen Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 55. FirstEigen Recent Development
Table 56. EVERSANA Company Details
Table 57. EVERSANA Business Overview
Table 58. EVERSANA Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 59. EVERSANA Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 60. EVERSANA Recent Development
Table 61. Ideagen Company Details
Table 62. Ideagen Business Overview
Table 63. Ideagen Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 64. Ideagen Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 65. Ideagen Recent Development
Table 66. Incepbio Company Details
Table 67. Incepbio Business Overview
Table 68. Incepbio Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 69. Incepbio Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 70. Incepbio Recent Development
Table 71. Exor International S.p.A. Company Details
Table 72. Exor International S.p.A. Business Overview
Table 73. Exor International S.p.A. Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 74. Exor International S.p.A. Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 75. Exor International S.p.A. Recent Development
Table 76. ComplianceQuest Company Details
Table 77. ComplianceQuest Business Overview
Table 78. ComplianceQuest Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 79. ComplianceQuest Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 80. ComplianceQuest Recent Development
Table 81. Vimachem Company Details
Table 82. Vimachem Business Overview
Table 83. Vimachem Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 84. Vimachem Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 85. Vimachem Recent Development
Table 86. Proscia Company Details
Table 87. Proscia Business Overview
Table 88. Proscia Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 89. Proscia Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 90. Proscia Recent Development
Table 91. Amplelogic Company Details
Table 92. Amplelogic Business Overview
Table 93. Amplelogic Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 94. Amplelogic Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 95. Amplelogic Recent Development
Table 96. Freyr Solutions Company Details
Table 97. Freyr Solutions Business Overview
Table 98. Freyr Solutions Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 99. Freyr Solutions Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 100. Freyr Solutions Recent Development
Table 101. Thermo Fisher SampleManager LIMS Company Details
Table 102. Thermo Fisher SampleManager LIMS Business Overview
Table 103. Thermo Fisher SampleManager LIMS Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 104. Thermo Fisher SampleManager LIMS Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 105. Thermo Fisher SampleManager LIMS Recent Development
Table 106. Dassault Systèmes Company Details
Table 107. Dassault Systèmes Business Overview
Table 108. Dassault Systèmes Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 109. Dassault Systèmes Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026) & (US$ Million)
Table 110. Dassault Systèmes Recent Development
Table 111. Data-Driven Quality Assurance in Pharma Manufacturing Market Trends
Table 112. Data-Driven Quality Assurance in Pharma Manufacturing Market Drivers
Table 113. Data-Driven Quality Assurance in Pharma Manufacturing Market Challenges
Table 114. Data-Driven Quality Assurance in Pharma Manufacturing Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Data-Driven Quality Assurance in Pharma Manufacturing Product Picture
Figure 2. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type: 2025 vs 2032
Figure 3. Real-time Monitoring Features
Figure 4. Statistical Quality Control Features
Figure 5. Others Features
Figure 6. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application: 2025 vs 2032
Figure 7. Process Development and Optimization
Figure 8. Production Process Control
Figure 9. Quality Inspection and Release
Figure 10. Supply Chain and Materials Management
Figure 11. Others
Figure 12. Data-Driven Quality Assurance in Pharma Manufacturing Report Years Considered
Figure 13. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 14. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Revenue, by Region: 2021 vs 2025
Figure 16. North America Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Europe Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. China Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Japan Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. India Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 22. South America Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. Middle East Data-Driven Quality Assurance in Pharma Manufacturing Revenue (US$ Million) Growth Rate (2021-2032)
Figure 24. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Players in 2025
Figure 25. Global Top Data-Driven Quality Assurance in Pharma Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Data-Driven Quality Assurance in Pharma Manufacturing as of 2025)
Figure 26. The Top 10 and 5 Players Market Share by Data-Driven Quality Assurance in Pharma Manufacturing Revenue in 2025
Figure 27. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
Figure 28. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
Figure 29. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
Figure 30. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
Figure 31. China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
Figure 32. China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
Figure 33. Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
Figure 34. Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
Figure 35. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
Figure 36. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
Figure 37. India Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2021-2026)
Figure 38. India Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2021-2026)
Figure 39. FirstEigen Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 40. EVERSANA Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 41. Ideagen Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 42. Incepbio Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 43. Exor International S.p.A. Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 44. ComplianceQuest Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 45. Vimachem Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 46. Proscia Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 47. Amplelogic Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 48. Freyr Solutions Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 49. Thermo Fisher SampleManager LIMS Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 50. Dassault Systèmes Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2021-2026)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 13.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Data-Driven Quality Assurance in Pharma Manufacturing market?
What is the annual compound growth rate of the global Data-Driven Quality Assurance in Pharma Manufacturing market size from 2026 to 2032?
What was the global market size of Data-Driven Quality Assurance in Pharma Manufacturing in 2032?
What was the global market size of Data-Driven Quality Assurance in Pharma Manufacturing in 2026?
Related Reports
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Data-Driven Quality Assurance in Pharma Manufacturing market is projected to grow from US$ 2379 million in 2025 to US$ 5600 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 137
USD 4900.00
(Single User License)
Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2379 million in 2025 and is projected to reach US$ 5600 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 115
USD 3950.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2026
The global Data-Driven Quality Assurance in Pharma Manufacturing market was valued at US$ 2379 million in 2025 and is anticipated to reach US$ 5600 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 118
USD 2900.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Data-Driven Quality Assurance in Pharma Manufacturing market size was US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published Date: 2025-05-16
Pages: 99
USD 4250.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2025
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was valued at US$ 2130 million in the year 2024 and is projected to reach a revised size of US$ 5006 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Published Date: 2025-05-16
Pages: 85
USD 2900.00
(Single User License)
Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published Date: 2025-05-16
Pages: 105
USD 3950.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Insights, Forecast to 2031
The global Data-Driven Quality Assurance in Pharma Manufacturing market is projected to grow from US$ 2379 million in 2025 to US$ 5006 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.2% during the forecast period.
Published Date: 2025-05-16
Pages: 137
USD 4900.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Data-Driven Quality Assurance in Pharma Manufacturing market is projected to grow from US$ 2379 million in 2025 to US$ 5600 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 137
USD 4900.00 (Single User License)Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2379 million in 2025 and is projected to reach US$ 5600 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 115
USD 3950.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2026
The global Data-Driven Quality Assurance in Pharma Manufacturing market was valued at US$ 2379 million in 2025 and is anticipated to reach US$ 5600 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 118
USD 2900.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Data-Driven Quality Assurance in Pharma Manufacturing market size was US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published: 2025-05-16
Pages: 99
USD 4250.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2025
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was valued at US$ 2130 million in the year 2024 and is projected to reach a revised size of US$ 5006 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Published: 2025-05-16
Pages: 85
USD 2900.00 (Single User License)Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published: 2025-05-16
Pages: 105
USD 3950.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Market Insights, Forecast to 2031
The global Data-Driven Quality Assurance in Pharma Manufacturing market is projected to grow from US$ 2379 million in 2025 to US$ 5006 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.2% during the forecast period.
Published: 2025-05-16
Pages: 137
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now